ArticleJournal of nanobiotechnology2026
pH-modulating binary hydrogen-bonded organic frameworks accelerate diabetic wound healing.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Diabetic foot ulcers have become an increasingly serious clinical problem, in which wound pH dysregulation and infection lead to impaired healing. To improve this situation, we propose a fabric coated with a binary hydrogen-bonded organic framework (SMU-8@W) to enhance wound healing efficiency. Specifically, the hydrogen-bonded organic framework (SMU-8) not only suppresses wound infection through its high photodynamic activity but also guides a "near-neutral-weakly acidic-near-neutral" pH transition at the wound site, thereby modulating the wound microenvironment. Moreover, SMU-8@W exhibits favorable hemostatic performance (BCI = 21.19 ± 2.52%), moisture permeability (5874.20 ± 196.03 g·m⁻²·d⁻¹), biosafety, and long-term stability, effectively managing wound exudate and alleviating inflammation, thereby accelerating wound healing. In summary, SMU-8@W offers a pH-modulating, infection-suppressing, angiogenesis-promoting, and collagen-enhancing therapeutic strategy for diabetic foot ulcers.
Indexed as
Identifiers
42332720What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.